ARWR stock

Arrowhead Pharmaceuticals Inc (ARWR) financials · rev $829.4M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Arrowhead Pharmaceuticals Inc (ARWR) rev $829.4M.

Cached annual income statement
LineFY2025FY2024
Revenue$829.4M$3.55M
Operating Income$98.3M-$601.1M
Net Income-$1.63M-$599.5M
EPS (Diluted)-$0.01-$5.00
Cached annual balance sheet
LineFY2025FY2024
Total Assets$1.39B$1.14B
Current Assets$950.6M$695.5M
PP&E$382.5M$386.0M
Total Liabilities$919.2M$954.4M
Current Liabilities$195.5M$103.2M
Shareholders' Equity$466.1M$185.4M
Retained Earnings-$1.63B-$1.63B
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow$179.6M-$462.9M
CapEx$22.7M$141.5M
Investing Cash Flow-$129.3M-$420.1M
Financing Cash Flow$74.0M$870.5M
Free Cash Flow$156.9M-$604.3M
These statements as JSON? API free 100/day

FAQ

What is ARWR P/E and revenue?

Arrowhead Pharmaceuticals Inc (ARWR) rev $829.4M.

What is ARWR revenue?

Arrowhead Pharmaceuticals Inc last cached revenue is $829.4M (FY2025).

Is ARWR profitable?

Arrowhead Pharmaceuticals Inc last cached net income is -$1.63M (FY2025).

What are ARWR total assets?

Arrowhead Pharmaceuticals Inc last cached total assets are $1.39B (FY2025).

What is ARWR free cash flow?

Arrowhead Pharmaceuticals Inc last cached free cash flow is $156.9M (FY2025).

Not investment advice. Cached statements, not a live tape.